NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,114 filers reported holding NOVARTIS A G in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,116,470 | +0.9% | 89,500 | 0.0% | 0.07% | +8.8% |
| Q2 2023 | $9,031,445 | +9.7% | 89,500 | 0.0% | 0.07% | +9.7% |
| Q1 2023 | $8,234,000 | +1.4% | 89,500 | 0.0% | 0.06% | -1.6% |
| Q4 2022 | $8,119,440 | +19.4% | 89,500 | 0.0% | 0.06% | +12.5% |
| Q3 2022 | $6,803,000 | -10.1% | 89,500 | 0.0% | 0.06% | -3.4% |
| Q2 2022 | $7,565,000 | -6.3% | 89,500 | -2.7% | 0.06% | +9.4% |
| Q1 2022 | $8,073,000 | +0.3% | 92,000 | 0.0% | 0.05% | +3.9% |
| Q4 2021 | $8,047,000 | +5.8% | 92,000 | -1.1% | 0.05% | +2.0% |
| Q3 2021 | $7,606,000 | -10.4% | 93,000 | 0.0% | 0.05% | -7.4% |
| Q2 2021 | $8,485,000 | +4.5% | 93,000 | -2.1% | 0.05% | 0.0% |
| Q1 2021 | $8,121,000 | -10.4% | 95,000 | -1.0% | 0.05% | -16.9% |
| Q4 2020 | $9,065,000 | +5.3% | 96,000 | -3.0% | 0.06% | -3.0% |
| Q3 2020 | $8,609,000 | -0.4% | 99,000 | 0.0% | 0.07% | -4.3% |
| Q2 2020 | $8,647,000 | +5.9% | 99,000 | 0.0% | 0.07% | -4.1% |
| Q1 2020 | $8,163,000 | -12.9% | 99,000 | 0.0% | 0.07% | +19.7% |
| Q4 2019 | $9,374,000 | +7.9% | 99,000 | -1.0% | 0.06% | +7.0% |
| Q3 2019 | $8,690,000 | -4.8% | 100,000 | 0.0% | 0.06% | -3.4% |
| Q2 2019 | $9,131,000 | -12.9% | 100,000 | -8.3% | 0.06% | -10.6% |
| Q1 2019 | $10,479,000 | -5.3% | 109,000 | -15.5% | 0.07% | -13.2% |
| Q4 2018 | $11,069,000 | -38.2% | 129,000 | -38.0% | 0.08% | -26.2% |
| Q3 2018 | $17,921,000 | +11.9% | 208,000 | -1.9% | 0.10% | +8.4% |
| Q2 2018 | $16,014,000 | -25.0% | 212,000 | -19.7% | 0.10% | -25.2% |
| Q1 2018 | $21,344,000 | -11.6% | 264,000 | -8.2% | 0.13% | -8.6% |
| Q4 2017 | $24,139,000 | -2.7% | 287,500 | -0.5% | 0.14% | -2.1% |
| Q3 2017 | $24,811,000 | -5.9% | 289,000 | -8.5% | 0.14% | -9.6% |
| Q2 2017 | $26,377,000 | +11.0% | 316,000 | -1.2% | 0.16% | +12.1% |
| Q1 2017 | $23,766,000 | +2.0% | 320,000 | 0.0% | 0.14% | +1.4% |
| Q4 2016 | $23,309,000 | -10.1% | 320,000 | -2.5% | 0.14% | -10.4% |
| Q3 2016 | $25,915,000 | -6.0% | 328,200 | -1.8% | 0.15% | -5.5% |
| Q2 2016 | $27,575,000 | +7.2% | 334,200 | -5.9% | 0.16% | +5.2% |
| Q1 2016 | $25,723,000 | -19.1% | 355,100 | -3.9% | 0.16% | -19.3% |
| Q4 2015 | $31,800,000 | -7.1% | 369,600 | -0.8% | 0.19% | -5.4% |
| Q3 2015 | $34,231,000 | -6.5% | 372,400 | 0.0% | 0.20% | +5.7% |
| Q2 2015 | $36,622,000 | -1.3% | 372,400 | -1.1% | 0.19% | +2.1% |
| Q1 2015 | $37,117,000 | +6.9% | 376,400 | +0.5% | 0.19% | +11.2% |
| Q4 2014 | $34,720,000 | -2.6% | 374,700 | -1.1% | 0.17% | -6.6% |
| Q3 2014 | $35,647,000 | +4.0% | 378,700 | 0.0% | 0.18% | +7.1% |
| Q2 2014 | $34,284,000 | +6.0% | 378,700 | -0.4% | 0.17% | +0.6% |
| Q1 2014 | $32,333,000 | +5.8% | 380,300 | 0.0% | 0.17% | +3.1% |
| Q4 2013 | $30,569,000 | +4.8% | 380,300 | 0.0% | 0.16% | -1.8% |
| Q3 2013 | $29,173,000 | +6.5% | 380,300 | -1.9% | 0.17% | 0.0% |
| Q2 2013 | $27,400,000 | – | 387,500 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |